Suppr超能文献

螯合剂对门克斯卷发综合征模型动物黄斑小鼠铜治疗的影响。

Effects of chelators on copper therapy of macular mouse, a model animal of Menkes' kinky disease.

作者信息

Tanaka K, Kobayashi K, Fujita Y, Fukuhara C, Onosaka S, Min K

机构信息

Department of Nutrition, Kobe-Gakuin University, Japan.

出版信息

Res Commun Chem Pathol Pharmacol. 1990 Aug;69(2):217-27.

PMID:2396048
Abstract

Effects of chelators on the copper(Cu) therapy for the mutant mouse, Macular, which is a model animal of Menkes' disease were studied. Simultaneous administration of some chelators reduced the necessary dose of Cu (10 mg/kg) for the survival of the mice to one tenth. By this treatment the Cu concentration in the brain was increased but Cu in the kidney was not increased as much as Cu administration without chelator. Surviving mice showed normal growth in terms of body weight and fertility. Furthermore same effects were observed even when the chelator was administered without Cu. In the chelators tested, derivatives of carbamic acid like dimethyldithiocarbamate, which forms a lipophilic complex with Cu, were effective.

摘要

研究了螯合剂对患有门克斯病的模型动物——突变小鼠黄斑铜(Cu)治疗的影响。同时给予某些螯合剂可将小鼠存活所需的铜剂量(10毫克/千克)降低至十分之一。通过这种治疗,大脑中的铜浓度增加,但肾脏中的铜增加量不如未使用螯合剂单独给予铜时多。存活的小鼠在体重和生育能力方面表现出正常生长。此外,即使在不给予铜的情况下给予螯合剂,也观察到了相同的效果。在所测试的螯合剂中,像二甲基二硫代氨基甲酸盐这样的氨基甲酸衍生物与铜形成亲脂性络合物,是有效的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验